CURE Pharmaceutical is changing how we take our medicines
By Chair of the Board Stacy Miller
Imagine a daily regimen of several pills, liquids or injections being reduced to a simple small film that dissolves in your mouth.
You don’t have to just imagine this great innovation because it is already developed by the brilliant team at CURE Pharmaceutical based right here in Oxnard.
CURE Pharmaceutical is a vertically integrated life science company with a propriety platform for oral drug delivery. The CURE mission is to improve lives by redefining how medicines are delivered and experienced, enabling more precise dosing and better efficiencies for patients.
By partnering with innovative firms looking for new methods to deliver drugs from early feasibility to commercialization, CURE Pharmaceutical is utilizing cutting-edge technology to solve a myriad of drug delivery issues.
“CURE’s oral soluble film technology is a versatile formulation platform that allows CURE to create proprietary drug products with optimal release profiles for better patient outcomes and experiences,” explains Jessica Rousset, CURE Pharmaceutical’s Chief Operating Officer.
From young children to the elderly and some in-between, the experience of taking pills, liquids and injections can be difficult. This can lead to poor medication adherence.
When swallowed, pills need to be dissolved by the body into particles small enough to be absorbed. During this process, as much as 80% of the drug may get metabolized by the liver and excreted.
While liquids can be offered as an alternative delivery method, they often taste terrible and can be challenging to administer to children and pets. Also, many patients strongly dislike injections, particularly when self-administered.
CUREfilm®, CURE Pharmaceutical’s marquis drug delivery system, is revolutionizing how medicines are consumed, solving the issues some have with pills, liquids and injections. CURE’s oral dissolving film technology unleashes the full potential of drug treatments and can improve the efficacy and safety of new and existing drugs, match or improve pharmacokinetic drug profiles, and stabilize plasma levels over extended time periods, possibly reducing dose frequency and side effects.
With CURE’s patented technology, life-saving drugs can be delivered to patients that bypass the G.I. tract, avoiding G.I. side effects and in activation in the gut and liver. This method protects the active ingredient from degradation in the biological environment; it prolongs the drug’s presence in the blood, and it increases cellular uptake. CURE’s technology is different from other oral thin films in that larger amounts of the drug active can be loaded onto the CUREfilm®.
Patient benefits of the CUREfilm® include rapid delivery for faster clinical affect and symptom relief; reduced side effects with a possible lower dose; an alternative to swallowing pills and injections; and easier adherence by combining multiple actives in one dose.
What else is on the horizon for this innovative company? How about raising the bar for cannabis by maximizing how cannabis can be used as an effective therapy for patients?
“We are very excited about the momentum at CURE Pharmaceutical. We are always looking at being collaborative not competitive, and we live by our company’s mission to improve people’s lives by redefining how medicines are delivered and experienced,” says Rousset.
What a great innovator right here in Oxnard! Check out CURE Pharmaceutical at: www.curepharma.com.